Showing 1 - 3 results of 3 for search 'Xavier Jaumont, MD', query time: 0.02s
Refine Results
-
1
Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma by Nicola A. Hanania, MD, Robert Niven, MD, Pascal Chanez, MD, PhD, Deschildre Antoine, MD, PhD, Pascal Pfister, MD, Lorena Garcia Conde, MD, Xavier Jaumont, MD
Published 2022-10-01
Article -
2
Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL by Francesco Menzella, MD, Jocelyne Just, MD, PhD, HDR, Inessa Schwab Sauerbeck, PhD, Claudia Mailaender, PhD, Fabiana Saccheri, PhD, Celine Thonnelier, Pharm D, Xavier Jaumont, MD, Laurence Mala, Pharm D
Published 2023-06-01
Article -
3
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab by Serge Doan, MD, Nikolaos G. Papadopoulos, MD, Jason K. Lee, MD, Salvatore Leonardi, MD, Sara Manti, MD, Susanne Lau, Carmen Rondon, Vibha Sharma, MD, Uwe Pleyer, MD, Xavier Jaumont, MD, Slawomir B. Lazarewicz, MD
Published 2023-06-01
Article